切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2026, Vol. 15 ›› Issue (03) : 166 -169. doi: 10.3877/cma.j.issn.2095-3216.2026.03.007

综述

机器学习驱动的IgA肾病精准治疗:疗效评估、预后预测及临床转化
黄霞, 张和平, 何永成()   
  1. 637000 南充,川北医学院附属医院肾病内科
  • 收稿日期:2025-10-29 出版日期:2026-06-28
  • 通信作者: 何永成
  • 基金资助:
    四川省医学科技创新研究会2024年科学研究项目(YCH-KY-YCZD2024-047)

Machine learning-driven precision treatment for IgA nephropathy: efficacy evaluation, prognostic prediction, and clinical translation

Xia Huang, Heping Zhang, Yongcheng He()   

  1. Department of Nephrology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China
  • Received:2025-10-29 Published:2026-06-28
  • Corresponding author: Yongcheng He
引用本文:

黄霞, 张和平, 何永成. 机器学习驱动的IgA肾病精准治疗:疗效评估、预后预测及临床转化[J/OL]. 中华肾病研究电子杂志, 2026, 15(03): 166-169.

Xia Huang, Heping Zhang, Yongcheng He. Machine learning-driven precision treatment for IgA nephropathy: efficacy evaluation, prognostic prediction, and clinical translation[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2026, 15(03): 166-169.

机器学习凭借其处理海量复杂数据的独特优势,为突破IgA肾病治疗及预后预测的现有瓶颈提供了新路径。在治疗决策方面,强化学习与多任务学习能够模拟不同临床干预方案的长期疗效,精准平衡治疗获益与潜在风险;在疗效评估方面,监督学习与图神经网络可有效筛选激素敏感型生物标志物,挖掘IgA肾病的关键分子通路;在预后预测方面,集成学习、DeepSurv等深度学习生存分析模型可实现IgA肾病的精细化风险分层,Transformer等时序模型则可动态追踪肾功能变化。本文综述了机器学习在IgA肾病精准治疗中的最新研究进展,及其在病理图像分析、移动健康平台等领域的应用现状,旨在推动IgA肾病由传统经验式治疗向数据驱动的精准治疗模式转变。

With its unique advantages in processing massive and complex data, machine learning has opened up new avenues to break through the existing bottlenecks in the treatment and prognostic prediction of IgA nephropathy. In terms of treatment decision-making, reinforcement learning and multi-task learning are capable of simulating the long-term efficacy of different clinical intervention plans, and accurately balance the therapeutic benefits and potential risks. In terms of efficacy evaluation, supervised learning and graph neural networks can effectively screen hormone-sensitive biomarkers and explore the key molecular pathways of IgA nephropathy. In terms of prognosis prediction, deep learning survival analysis models such as ensemble learning and DeepSurv can achieve refined risk stratification for IgA nephropathy, while temporal models including Transformer can dynamically track changes in renal function. This paper reviews the latest research progress of machine learning in the precise treatment of IgA nephropathy, as well as its application status in fields such as pathological image analysis and mobile health platforms, aiming to promote the transformation of IgA nephropathy treatment from traditional empirical therapy to a data-driven precision treatment mode.

表1 不同机器学习方法在IgA肾病诊疗中的应用
[1]
Pattrapornpisut P, Avila-Casado C, Reich HN. IgA nephropathy: core curriculum 2021 [J]. Am J Kidney Dis, 2021, 78(3): 429-441.
[2]
Ghaddar M, Canney M, Barbour SJ. IgA nephropathy: epidemiology and disease risk across the world [J]. Semin Nephrol, 2024, 44(5): 151564.
[3]
史彬,司远. 益气和络方联合缬沙坦治疗气阴两虚兼血瘀证IgA肾病的疗效观察[J/OL]. 中华肾病研究电子杂志2024, 13(6): 306-312.
[4]
Medjeral-Thomas NR, Cook HT, Pickering MC. Complement activation in IgA nephropathy [J]. Semin Immunopathol, 2021, 43(5): 679-690.
[5]
Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases [J]. Kidney Int, 2021, 100(4): 753-779.
[6]
Crampon K, Giorkallos A, Deldossi M, et al. Machine-learning methods for ligand-protein molecular docking [J]. Drug Discov Today, 2022, 27(1): 151-164.
[7]
Floege J, Bernier-Jean A, Barratt J, et al. Treatment of patients with IgA nephropathy: a call for a new paradigm [J]. Kidney Int, 2025, 107(4): 640-651.
[8]
Oosterom-Eijmael MJP, Hermanides J, van Raalte DH, et al. Risk of perioperative discontinuation of SGLT2 inhibitors [J]. Br J Anaesth, 2024, 133(2): 239-240.
[9]
Yaseen K, Herlitz LC, Villa-Forte A. IgA vasculitis in adults: a rare yet challenging disease [J]. Curr Rheumatol Rep, 2021, 23(7): 50.
[10]
Noda R, Ichikawa D, Shibagaki Y. Machine learning-based diagnostic prediction of IgA nephropathy: model development and validation study [J]. Sci Rep, 2024, 14(1): 12426.
[11]
Nestler S, Humberg S. A Lasso and a regression tree mixed-effect model with random effects for the level, the residual variance, and the autocorrelation [J]. Psychometrika, 2022, 87(2): 506-532.
[12]
Coppo R, Troyanov S, Bellur S, et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments [J]. Kidney Int, 2014, 86(4): 828-836.
[13]
Hongyu C, Xinyi Z, Zeng W, et al. A prognostic model of immunoglobulin A nephropathy using artificial neural network: a retrospective study based on integrated Chinese and Western Medicine [J]. J Tradit Chin Med, 2025, 45(3): 676-684.
[14]
Zhang H, Rizk DV, Perkovic V, et al. Results of a randomized double-blind placebo-controlled phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy [J]. Kidney Int, 2024, 105(1): 189-199.
[15]
Gesualdo L, Di Leo V, Coppo R. The mucosal immune system and IgA nephropathy [J]. Semin Immunopathol, 2021, 43(5): 657-668.
[16]
Pan S, Fu Y, Chen P, et al. Multi-task learning-based immunofluorescence classification of kidney disease [J]. Int J Environ Res Public Health, 2021, 18(20): 10798.
[17]
Li B. The npj digital medicine editorial fellowship [J]. NPJ Digit Med, 2025, 8(1): 638.
[18]
Pan M, Li M, Li N, et al. Predicting renal damage in children with IgA vasculitis by machine learning [J]. Pediatr Nephrol, 2024, 39(10): 2997-3004.
[19]
Fayyaz AM, Abdulkadir SJ, Talpur N, et al. Grad-CAM (Gradient-weighted Class Activation Mapping): a systematic literature review [J]. Comput Biol Med, 2025, 198(Pt B): 111200.
[20]
Obermeyer Z, Emanuel EJ. Predicting the future - big data, machine learning, and clinical medicine [J]. N Engl J Med, 2016, 375(13): 1216-1219.
[21]
Flach RN, Stathonikos N, Nguyen TQ, et al. CONFIDENT-trial protocol: a pragmatic template for clinical implementation of artificial intelligence assistance in pathology [J]. BMJ Open, 2023, 13(6): e067437.
[22]
Gulamali FF, Nadkarni GN. Federated learning in risk prediction: a primer and application to COVID-19-associated acute kidney injury [J]. Nephron, 2023, 147(1): 52-56.
[23]
Hanser T. Federated learning for molecular discovery [J]. Curr Opin Struct Biol, 2023, 79: 102545.
[24]
Thangaraj PM, Benson SH, Oikonomou EK, et al. Cardiovascular care with digital twin technology in the era of generative artificial intelligence [J]. Eur Heart J, 2024, 45(45): 4808-4821.
[25]
Sadée C, Testa S, Barba T, et al. Medical digital twins: enabling precision medicine and medical artificial intelligence [J]. Lancet Digit Health, 2025, 7(7): 100864.
[26]
Kano T, Suzuki H, Makita Y, et al. Lessons from IgA nephropathy models [J]. Int J Mol Sci, 2024, 25(21): 11484.
[27]
Kumuthini J, van Woerden C, Mallett A, et al. Proposed minimum information guideline for kidney disease-research and clinical data reporting: a cross-sectional study [J]. BMJ Open, 2019, 9(11): e029539.
[28]
Zhao Y, Cao L, Ji Y, et al. Interpretable EEG emotion classification via CNN model and gradient-weighted class activation mapping [J]. Brain Sci, 2025, 15(8): 886.
[29]
Chen D, He E, Pace K, et al. Concordance with SPIRIT-AI guidelines in reporting of randomized controlled trial protocols investigating artificial intelligence in oncology: a systematic review [J]. Oncologist, 2025, 30(5): oyaf112.
[30]
Watson CPN, Midha R, Ng DW. Causalgia: a review of nerve resection, amputation, immunotherapy, and amputated limb CRPS II pathology [J]. Can J Neurol Sci, 2024, 51(3): 351-356.
[31]
Mosquera-Lopez C, Jacobs PG. Digital twins and artificial intelligence in metabolic disease research [J]. Trends Endocrinol Metab, 2024, 35(6): 549-557.
[32]
Yao JF, Yang Y, Wang XC, et al. Systematic review of digital twin technology and applications [J]. Vis Comput Ind Biomed Art, 2023, 6(1): 10.
[33]
Zhao F, Wu Y, Hu M, et al. Current progress of digital twin construction using medical imaging [J]. J Appl Clin Med Phys, 2025, 26(9): e70226.
[34]
Aghamiri SS, Amin R. The potential use of digital twin technology for advancing CAR-T cell therapy [J]. Curr Issues Mol Biol, 2025, 47(5): 321.
[35]
de Lepper AGW, Buck CMA, van′t Veer M, et al. From evidence-based medicine to digital twin technology for predicting ventricular tachycardia in ischaemic cardiomyopathy [J]. J R Soc Interface, 2022, 19(194): 20220317.
[1] 丁彩霞, 曲景辉, 裴英宏, 李静娜, 郑晓瑜, 徐岭植, 李思思. 基于RNA结合蛋白基因表达特征的乳腺癌预后预测模型构建及评价分析[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(03): 138-147.
[2] 黄家骏, 周奕延, 王斐然, 何志贤. 系统性红斑狼疮与乳腺癌关系的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(03): 179-183.
[3] 付丽坤, 崔红梅, 高福来, 乔红, 冯钟煦. 腹腔镜下胆总管探查“T”管引流术与经胆囊管胆总管探查取石术治疗继发性胆总管结石的疗效对比[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 226-230.
[4] 辛林璞, 杨敏, 杜峻峰. 腹腔镜结直肠癌根治术后常见并发症防治与管理[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 248-251.
[5] 黄楚曦, 吴卓. 人工智能在膀胱癌影像中的应用进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(03): 241-247.
[6] 徐宏博, 胡玉良, 魏雪栋, 金李晨, 武克风, 陈逸伦, 陆兵, 周守军, 侯建全. 基于临床和CT影像组学特征的机器学习模型对经皮肾镜术后脓毒症的预测价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(03): 297-306.
[7] 李旭柯, 熊培尧, 杨子良, 敖玉凤, 徐立. 肿瘤包绕型血管在接受仑伐替尼治疗肝癌患者生存预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(03): 346-354.
[8] 叶金宝, 梁声强, 马建新, 林小强, 张海森. 小野寺预后营养指数对肝癌复发预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(03): 372-378.
[9] 马凯蒂, 哈团结. 基于机器学习的糖尿病肾脏病患者疲乏状态诊断预测模型构建[J/OL]. 中华肾病研究电子杂志, 2026, 15(03): 144-150.
[10] 杨卫红, 郭向飞. 糖尿病合并慢性肾脏病患者血清前白蛋白和白蛋白/球蛋白比值与肾功能及预后的相关性研究[J/OL]. 中华肾病研究电子杂志, 2026, 15(03): 151-157.
[11] 中国研究型医院学会放射学专业委员会, 上海抗癌协会实体肿瘤聚焦诊疗专业委员会. 血管包裹肿瘤簇在肝细胞癌影像诊疗中的临床应用专家共识(2026年版)[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(03): 193-198.
[12] 齐洪武, 徐泽雨. 脑脓肿的临床诊治进展[J/OL]. 中华临床医师杂志(电子版), 2026, 20(04): 327-331.
[13] 柳云鹏, 贾建文, 黄菊梅, 汪阳. 早期血压变异性对大血管闭塞性急性缺血性脑卒中术后神经功能恢复的影响[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(03): 274-279.
[14] 吴嶛, 蔡诗昆, 左鹏, 倪贵华, 倪小宇. 急性缺血性脑卒中机械取栓前血栓迁移与临床资料的相关性[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(03): 287-293.
[15] 梁怡凡, 牟婧宇, 吴雅婷, 邳靖陶, 陈乐, 武剑. 不同人工智能模型预测脑卒中不良预后诊断效能的荟萃分析[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(03): 308-319.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?